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Abstract
Despite current scientific evidence that artificial feeding is a harmful practice, unquestioned
acceptance of breastfeeding as the normal or "default" method of infant feeding remains elusive in
the industrialised world. Throughout the developing world the profound consequences of the
aggressive marketing strategies of the infant formula industry since the end of the Second World
War is well known. A key objective of the International Breastfeeding Journal is to promote
breastfeeding through addressing issues that encourage breastfeeding initiation, duration and
effective management. Informing this aim is the recognition of artificial feeding as a harmful practice
that places infant health at risk. From this perspective it would be unethical for this journal to accept
for publication any manuscript that has received funding, sponsorship or any other means of
support from infant formula manufacturers. This stance is consistent with the journal's aim of
supporting, protecting and promoting breastfeeding. It will also contribute to the promotion of a
breastfeeding culture.
Editorial
Despite current scientific evidence that artificial feeding is
a harmful practice [1], unquestioned acceptance of breast-
feeding as the normal or "default" method of infant feed-
ing [2] remains elusive throughout the industrialised
world. The dominance of an infant formula feeding cul-
ture is evident through popular beliefs such as "artificial
milk feeds [are]...at least as good for the baby (if not actu-
ally better) as breast feeding", and ambivalent views asso-
ciated with "give it a go" attitudes [3]. This lack of a
breastfeeding culture in most industrialised nations is the
legacy of decades of commercial marketing of infant for-
mula, often endorsed by medical practices [4].
Throughout the developing world the profound conse-
quences of the aggressive marketing strategies of the
infant formula industry particularly since the end of the
Second World War is well known. Public awareness of the
tragic outcome of the use of infant formula in the devel-
oping world led to a consumer boycott of Nestlé products
during the late 1970s and early 1980s. Around this time
the first of a series of international strategies designed to
reduce infant mortality rates through regulating the pro-
motion of artificial baby milk was implemented. In 1981,
the World Health Organization (WHO) announced the
International Code of Marketing of Breast-milk Substi-
tutes [5]. The aim of the International Code was "to con-
tribute to the provision of safe and adequate nutrition for
infants, by the protection and promotion of breast-feed-
ing, and by ensuring the proper use of breast-milk substi-
tutes, when these are necessary, on the basis of adequate
information and through appropriate marketing and dis-
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tribution" [5] (p.8). While a significant move, universal
implementation of the International Code has been ham-
pered by the difficulty of enforcing compliance among
members of the infant formula industry and within non-
signatory nations.
Following the launch of the International Code, the
World Health Assembly has issued a succession of policy
statements designed to increase global breastfeeding rates.
Of particular significance was the 1989 joint WHO/
UNICEF statement on the Protection, Promotion and Sup-
port of Breastfeeding: the Ten Steps to Successful Breastfeeding
[6]. This statement aimed "to encourage hospitals and
healthcare facilities to adopt practices that fully protect,
promote and support breastfeeding". The internationally
applicable Baby Friendly Hospital Initiative is currently
the central aspect of a global strategy designed to foster the
initiation of breastfeeding at the time of birth [7].
Despite several decades of initiatives by organisations
such as WHO, UNICEF and other non-government bod-
ies, for example, World Alliance for Breastfeeding Action,
progress in fostering a breastfeeding culture among the
industrialised nations has been slow. Hampered by the
ideology of consumer choice that promotes a woman's
right to decide the method of infant feeding that best suits
her lifestyle and worldview, the goal of unquestioned
acceptance of breastfeeding as the norm remains elusive.
Not only does a consumer culture disregard the right of
every infant to be breastfed, but it also fosters accusations
that promotion of breastfeeding leads to guilt among
those unwilling or unable to successfully establish and
maintain lactation. Overlooked by such claims is the
hegemonic influence of the infant formula industry, pro-
moted and sustained over decades of marketing of artifi-
cial baby milk. As Wiessinger points out, the industry's
influence has permeated even the language employed by
health professionals to encourage women to breastfeed
[8]. For example, promotion of the "advantages" of
breastfeeding mimics the commercial sales pitch adopted
by the formula industry and so endorses the notion of
consumer choice. Wiessinger argues that because breast-
feeding is the biological norm, breastfed babies should
not be perceived as "healthier", nor do they "smell better"
than formula-fed infants and so on [8] (p1). Breastfed
babies are simply "normal"!
The profound consequences of the harmful impact of for-
mula marketing practices have generated ethical debate
over any form of support received from the artificial baby
milk industry. In the late 1990s, Lucas argued that "pro-
vided . . . researchers declare their funding sources, they
should not be censored for industrial collaborative
research into child health" [9] (p. 337) because "formula
companies provide a critical contribution to infant health
care, health education, and high quality research" [9]
(p.338). Others strongly disagreed [10-12]. Rundall
pointed out that sponsorship is "a payment by a business
firm . . . for the purposes of promoting its name, products
or services. It is a commercial deal, not a philanthropic
gift" [10] (p338). She argued that companies use sponsor-
ship as a marketing strategy to create the image that they
are responsible corporate citizens and to link their name
to prestigious organisations and doctors [10]. Others
mentioned the "inevitability of bias towards formula
feeding in those who take money from the industry" [11]
p 260.
"Sponsorship bias" in pharmaceutical research has been
confirmed; a meta-analysis found industry sponsorship
was associated with an odds of 3.6 (95% Confidence
Interval [CI] 2.63, 4.91) of a pro-industry conclusion [13].
A recent systematic review of nutrition-related scientific
articles focusing on soft drinks, juices and cow milk,
examined the relationship between funding source and
conclusion [14]. Again, industry funding was found to
favour the sponsor's products. The odds of an article
reporting a conclusion favourable to the nutrition indus-
try versus an unfavourable conclusion was 7.61 (95% CI
1.27, 45.73) comparing articles with all industry funding
to no industry funding [14]. Among the possible ways to
reduce bias in nutrition articles, the authors suggested vol-
untary refusal by scientists to accept industrial support
and the implementation of more stringent policies by
journals over the publication of industry-sponsored
research [14].
The call to eliminate commercial bias from scientific pub-
lications on infant nutrition is consistent with the spirit of
the International Code of Marketing of Breast Milk Substi-
tutes. In Britain, for example, direct to the public advertis-
ing of formula for infants aged under six months is
prohibited in compliance with the International Code.
Despite this law, formula advertising remains permitted
in health professional journals provided information is
restricted to "a scientific and factual nature" [15]. In light
of the findings of sponsor bias in nutrition articles, the
argument that there is a need to disseminate infant feed-
ing information to all parents in the interests of infant
well-being becomes highly questionable. Recently, Magda
Sachs, one of the members of the International Breastfeed-
ing Journal's Editorial Board, challenged the situation
arguing, "Milk company advertising has no place in repu-
table journals", particularly in Britain where it represents
attempts by the industry 'to circumvent the [country's]
ban on direct advertising to mothers" [15] (p. 714). She
also expressed concern that infant formula advertising
may "entice [health] professionals to abandon their inde-
pendence as practitioners" [15] (p. 714). Sachs made the
comments in response to the pro-advertising stance ofPublish with BioMed Central    and   every 
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British Journal of Midwifery managing director and pub-
lisher, Mark Allen. Among other things, Allen advocates
the parents' right of choice, and concern that exclusion of
infant formula advertising would discriminate against
parents who do not breastfeed [16]. Informing Allen's
stance is the view that "we are professional publishers, not
moral guardians" [16] (p. 715).
The Sachs/Allen debate draws attention to the challenges
that need to be overcome if breastfeeding is to be accepted
as the unquestioned "default" method of infant feeding.
Central to this challenge are the ethics of the industry's
funding, sponsorship and support of infant feeding
research. Not only does such patronage jeopardise the
independence of researchers and health professionals
alike but more importantly it promotes and sustains a for-
mula feeding culture.
A key objective of the International Breastfeeding Journal is
to promote breastfeeding through addressing issues that
encourage breastfeeding initiation, duration and effective
management. Informing this aim is the recognition of
artificial feeding as a harmful practice that places infant
health at risk. From this perspective it would be unethical
for this journal to accept for publication any manuscript
that has received funding, sponsorship or any other
means of support from infant formula manufacturers.
This stance is consistent with the journal's aim of support-
ing, protecting and promoting breastfeeding. It will also
contribute to the promotion of a breastfeeding culture.
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